Previous expression-profiling studies have suggested that enhanced PRSS23 expression is observed in various types of cancers, including breast [4], [5], [6], prostate [7], papillary thyroid [8], and pancreatic cancers [9], and the expression of the PRSS23 has been linked with tumor progression in human [1]. The gene discussed is PRSS23; the disease is neoplasm.